Rules - 2021

Drug Scheduling Actions

Final Rule: Removal of Samidorphan From Control (April 19, 2021)

Final Rule: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I; Correction (March 31, 2021)

Extension of Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA and FUB-144 in Schedule I of the Controlled Substances Act (March 31, 2021)

Final Rule: Placement of Lemborexant in Schedule IV (March 3, 2021)

Temporary Placement of Brorphine in Schedule I (March 1, 2021)

Proposed Rules

Proposed Rule: Designation of Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine, as a List I Chemical (March 30, 2021)

Proposed Rule: Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA and FUB-144 in Schedule I (March 30, 2021)

Proposed Rule: Placement of Four Specific Fentanyl-Related Substances in Schedule I (March 18, 2021)

Proposed Rule: Placement of 10 Specific Fentanyl-Related Substances in Schedule I (March 3, 2021)

Proposed Rule; Reopening of Comment Period: Suspicious Orders of Controlled Substances (February 25, 2021)

Proposed Rule: Amending Regulations To Require Online Submission of Applications for and Renewals of DEA Registration (PDF) (January 7, 2021)

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Rules - 2021

Drug Scheduling Actions

Proposed Rules

The United States Department of Justice